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This study shows HIV-1 incidence in the northeastern region of Brazil, where the HIV epidemic has spread recently. Incidence
was higher amongmen (1.34%; 95% confidence interval [CI], 1.00% to 1.69%) than among women (0.55%; 95% CI, 0.43% to
0.68%) (P< 0.0001), and there was an association between younger age and recent HIV infection (P< 0.004).
The identification of recent infections through immunoassaysprovides important data for evaluating intervention policies,
guiding preventionmethods, andmonitoring antiretroviral resis-
tance in newly diagnosed individuals when performed in parallel
with genotypic assays andmay be useful in the selection of cohorts
for vaccine and clinical trial follow-ups (3, 6, 8, 10, 13).
The introduction of an algorithm for serological testing and the
use of a sensitive/less-sensitive (detuned) immunoassay that enables
the identification of recent HIV-1 infection represents an important
advance in this area (7). This approach is referred to as the serological
testing algorithm for recentHIV seroconversion (STARHS), and the
BED-capture enzyme immunoassay (BED-CEIA) is a currently used
assay able to determine the incidence of HIV-1 (11).
The present study was conducted to determine the annual in-
cidence of HIV-1 infection in two voluntary counseling testing
(VCT) centers in the metropolitan region of Recife (Pernam-
buco), located in the northeastern region of Brazil, and to examine
the association of epidemiological characteristics with duration of
the infection (recent or long-term). For this purpose, the BED-
CEIA test for HIV-1 incidence (Calypte Biomedical Corporation,
Oregon) was performed in accordance with the manufacturer’s
instructions and as previously described (5, 11). Samples with a
normalized optical density (ODn) of1.2 were classified as long-
term infections, and for those with an ODn of1.2, the test was
performed in triplicate. Samples were considered to be indicative
of a recent infection if the median of the triplicate measurements
of the ODn was0.8 (9). Incidence calculation was performed as
suggested by the U.S. Centers for Disease Control and Prevention
(CDC) (2), and adjustment factors for the sensitivity and specific-
ity of the test (9) were subsequently applied.
Between January 2006 and December 2009, 497 HIV-positive
patients were diagnosed in two VCT centers (Cabo de Santo Ag-
ostinho and Paulista) in Pernambuco, and 375 aliquots from these
patients (77%) were available for BED-CEIA testing, with the
samples being obtained from the serum repositories of the VCT
center of origin. Samples in which antiretroviral therapy (ART)
had been previously used, vertical transmission was reported, or
HIVwas detected via serological testingmore than 6months prior
to the collection of the sample were excluded. All patients whose
samples were used in the study had been diagnosed with HIV
infection in accordance with the Brazilian Ministry of Health
guidelines. Each case was serologically confirmed by enzyme im-
munoassay, and immunofluorescence or Western blotting was
performed as a confirmatory test with two independent serum
samples.
Most of the individuals were women (52%) and had8 years
of schooling (65.1%). Regarding risk exposure,most patientswere
heterosexual (86.7%) and 27 patients (7.2%) reported having had
sexual intercourse with HIV-positive partners. The median age
was 29 years (range, 24 to 37 years), and a univariate analysis
indicated an association between younger age and recent HIV
infection inwhich individualswith recent and long-term infection
had median ages of 27 years (range, 22 to 35 years) and 30 years
(range, 24 to 37 years), respectively (P 0.004).
The results obtained are shown in Table 1. One hundred five
(28%) of 375 patients were classified as recent infections. No sig-
nificant differences were observed with respect to fluctuations in
the incidence and prevalence over the years of the study. The prev-
alence ranged from 1.22% to 1.50%, while the incidence ranged
from 0.62% to 0.91%. The overall incidence was 0.73% per year
(95% confidence interval [CI], 0.61% to 0.86%), and the overall
prevalence was 1.31% (95% CI, 1.19% to 1.43%) per year. The
overall sample analysis indicated that the incidence among men
was significantly higher than that among women, at 1.34% per
year (95% CI, 1.00% to 1.69%) for men and 0.55% (95% CI,
0.43% to 0.68%) for women (P  0.0001). The prevalence was
also higher among men, at 2.80% (95% CI, 2.45% to 3.15%)
amongmen and 0.87% (95%CI, 0.77% to 0.97%) among women
(P 0.0001), a pattern that has also been observed in other studies
(1, 12). The higher prevalence and incidence among men may be
accounted for by the predominance of the epidemic among men
despite the growing number of women with AIDS in Brazil (4).
The incidence of recent infection among womenmay be underes-
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timated by the overrepresentation of pregnant women at the VCT
centers or by the greater demand among women for health ser-
vices in general.
The female patients from the Paulista VCT center were strati-
fied as pregnant or nonpregnant. In the nonpregnant group, the
respective prevalence and incidence were 1.44% (95% CI, 1.09%
to 1.79%) and 0.44% (95% CI, 0.18% to 0.70%), whereas among
the pregnant women, the prevalence and incidence were 0.36%
(95% CI, 0.20% to 0.52%) and 0.18% (95% CI, 0.02% to 0.34%),
respectively. The differences in the incidence and prevalence be-
tween pregnant women and other VCT volunteers indicate that
these populations have distinct epidemiological characteristics
with respect to risk of exposure. A lower incidence and prevalence
among pregnant women may be expected because HIV testing is
compulsory for all pregnant women in Brazil.
Major variations in the incidence were observed for males,
with a significant increase (P  0.0034) from 0.83% (95% CI,
0.32% to 1.34%) in 2008 to 1.78% (95% CI, 1.01% to 2.55%) in
2009. For females, the incidence rates significantly decreased (P
0.000021) from 0.75% (95% CI, 0.46% to 1.04%) in 2007 to
0.25% (95% CI, 0.10% to 0.39%) in 2009.
The present study is the first to determine HIV-1 incidence
using STARHS in the northeastern region of Brazil, where theHIV
epidemic has spread recently, although it is exhibiting a decline in
the southeastern and central-western regions of the country (4). A
higher estimated incidence was observed among men, and
younger individuals had a higher rate of recent HIV infection,
which indicates that this demographic category requires a greater
focus on preventionmeasures, such as greater access to serological
testing and the use of more specifically targeted strategies. Fur-
thermore, the HIV epidemic trends should be continuously mon-
itored over time in specific groups that potentially have an increas-
ing incidence.
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TABLE 1 Annual number of recent infections, prevalence, and incidence of HIV-1, as estimated using the BED-CEIA, from 2006 to 2009
Yr or sex
No. of individuals:
Prevalence (%)
(95% CI) P value
No. (%) of individuals with:
Adjusted incidence (%)
(95% CI)d P valueTested
HIV
positivea
HIV
negative
BED-tested
samplesb Recent infectionc
2006 9,042 111 8,931 1.23 (1.00–1.46) 0.276 66 (61.1) 18 (27.3) 0.66 (0.42-0.90) 0.103
2007 9,383 141 9,242 1.50 (1.25–1.75) 98 (70.5) 29 (29.6) 0.91 (0.63-1.18)
2008 9,330 122 9,208 1.31 (1.08–1.51) 118 (99.2) 34 (28.8) 0.75 (0.50-1.01)
2009 10,121 123 9,998 1.22 (1.00–1.44) 93 (76.8) 24 (25.8) 0.62 (0.40-0.83)
Male 8,692 243 8,449 2.80 (2.45–3.15) 0.0001 180 (75) 44 (24.4) 1.34 (1.00-1.69) 0.0001
Female 29,184 254 28,930 0.87 (0.77–0.97) 195 (78.9) 61 (31.3) 0.55 (0.43-0.68)
Total 37,876 497 37,379 1.31 (1.19–1.43) 375 (77) 105 (28) 0.73 (0.6-0.86)
a Represents the total number of individuals serologically diagnosed with HIV infection. A total of 10 HIV-positive patients were excluded from the incidence calculation: eight had
had a previous positive serological test for HIV, one was a case of vertical transmission, and one was undergoing antiretroviral treatment. Three of these individuals were from the
2006 cohort, two were from the 2007 cohort, three were from the 2008 cohort, and two were from the 2009 cohort.
b Total number of available aliquots among the total number of HIV-positive samples eligible for BED-CEIA testing (excluding the 10 HIV-positive patients).
c Proportion of recent infections out of the total number of samples tested using BED-CEIA.
d Calculated in accordance with McDougal et al. (9). The results are expressed as the incidence/100 people/year (95% CI).
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